Cite
HARVARD Citation
Nakajo, M. et al. (2021). A pilot study on EORTC or PERCIST for the prediction of progression-free survival with nivolumab therapy in advanced or metastatic gastric cancers. Medicine. 100 (15), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Nakajo, M. et al. (2021). A pilot study on EORTC or PERCIST for the prediction of progression-free survival with nivolumab therapy in advanced or metastatic gastric cancers. Medicine. 100 (15), p. . [Online].